EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical characteristics, molecular epidemiology and mechanisms of colistin heteroresistance in Enterobacter cloacae complex

Chunli Wei, Jiming Wu, Jisheng Zhang, Youtao Liang, Kaixin Yu, Mingjing Liao, Xushan Liang, Jianmin Wang, Wenzhang Long, Jin Wang, Shijian Chen, Yang Yang und 3 weitere

Frontiers in Cellular and Infection Microbiology · 2025

DOI: 10.3389/fcimb.2025.1536058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Chunli Wei und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Yongchuan Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Colistin, Enterobacteriaceae Infections, Anti-Bacterial Agents, Enterobacter cloacae. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Colistin has emerged as the last resort for treating multidrug-resistant Enterobacter cloacae complex (ECC) infections. The primary purposes of this study were to demonstrate the presence of colistin heteroresistance in ECC and to further investigate their clinical characteristics, molecular epidemiology and mechanisms.

Methods

Population analysis profiles (PAP) were performed to confirm the heteroresistance phenotype. Average nucleotide identity (ANI) was determined to classify ECC species. Phylogenetic analysis based on core genome single nucleotide polymorphisms (cg-SNPs), multilocus sequence typing (MLST) and core genome MLST (cg-MLST). Risk factors and clinical outcomes of infections were analyzed through a retrospective case-control study. Potential mechanisms of colistin heteroresistance were evaluated using polymerase chain reaction (PCR), efflux pump inhibition assays and reverse transcription quantitative PCR (RT-qPCR).

Results

A high proportion (24.4%) of the non-resistant strains were colistin-heteroresistant isolates. Among the several ECC species, Enterobacter kobei had the largest percentage (29.4%) of colistin-heteroresistant isolates, followed by Enterobacter hormaechei (20.5%) and Enterobacter bugandensis (20.0%). Notably, only one strain (0.8%; 1/132) of Enterobacter hormaechei was fully resistant to colistin. Different ECC species showed varying heteroresistance levels: Enterobacter roggenkampii , Enterobacter kobei , Enterobacter asburiae and Enterobacter bugandensis displayed high heteroresistance levels (MIC ≥ 128 mg/L). 75% of all ST116 and ST56 strains were heteroresistant to colistin. The infection of ST116 and ST56 strains as well as exposure to cephalosporin antibiotics were independent risk factors for colistin-heteroresistant ECC infections. Mechanistic analysis revealed that heteroresistance strongly correlated with the overexpression of arnA , regulated by the PhoPQ two-component system (TCS). Notably, mgrB had minimal impact. AcrAB-TolC efflux pump genes showed unsynchronized expression; High acrB expression was strongly associated with colistin heteroresistance, while acrA and tolC were not.

Discussion

Colistin heteroresistance showed species-dependent variations in levels and prevalence rates. The colistin-heteroresistant mechanisms were complex, involving coordinated regulation of multiple genes. These results highlighted the need for tailored antimicrobial stewardship. In addition, the development of direct, reliable and rapid clinical methods for detecting heteroresistance is essential for improving infection management and prevention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColistinEnterobacteriaceae InfectionsAnti-Bacterial AgentsEnterobacter cloacaeDrug Resistance, BacterialHumansMolecular EpidemiologyMultilocus Sequence TypingPhylogenyMaleRetrospective StudiesFemaleMicrobial Sensitivity TestsCase-Control StudiesEnterobacterMiddle AgedDrug Resistance, Multiple, BacterialAgedPolymorphism, Single NucleotideAdultGenome, Bacterial

Stichwörter der Autor:innen

Enterobacter cloacae complexcolistin heteroresistancemechanismsprevalenceresistant subpopulationsrisk factors

Substanzen

ColistinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Microbiology, Yongchuan Hospital of Chongqing Medical University, Chongqing, China.
  • Department of Pathogenic Biology, Basic Medicine of Jiamusi University, Jiamusi, China.

Zitieren

APA

Wei, C., Wu, J., Zhang, J., Liang, Y., Yu, K., Liao, M., Liang, X., Wang, J., Long, W., Wang, J., Chen, S., Yang, Y., Gong, X., Li, J., & Zhang, X. (2025). Clinical characteristics, molecular epidemiology and mechanisms of colistin heteroresistance in Enterobacter cloacae complex. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1536058

Vancouver

Wei C, Wu J, Zhang J, Liang Y, Yu K, Liao M, et al. Clinical characteristics, molecular epidemiology and mechanisms of colistin heteroresistance in Enterobacter cloacae complex. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1536058

BibTeX
@article{Wei2025,
  author = {Wei, Chunli and Wu, Jiming and Zhang, Jisheng and Liang, Youtao and Yu, Kaixin and Liao, Mingjing and Liang, Xushan and Wang, Jianmin and Long, Wenzhang and Wang, Jin and Chen, Shijian and Yang, Yang and Gong, Xue and Li, Jie and Zhang, Xiaoli},
  title = {Clinical characteristics, molecular epidemiology and mechanisms of colistin heteroresistance in Enterobacter cloacae complex},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2025.1536058}
}
Kostenlos starten →